Organogenesis Holdings Inc (NASDAQ: ORGO) kicked off on Friday, up 13.60% from the previous trading day, before settling in for the closing price of $3.75. Over the past 52 weeks, ORGO has traded in a range of $2.16-$6.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 14.32% over the past five years. While this was happening, its average annual earnings per share was recorded 626.00%. With a float of $64.38 million, this company’s outstanding shares have now reached $125.73 million.
Let’s look at the performance matrix of the company that is accounted for 869 employees. In terms of profitability, gross margin is 74.32%, operating margin of -0.27%, and the pretax margin is -0.58%.
Organogenesis Holdings Inc (ORGO) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Organogenesis Holdings Inc is 49.24%, while institutional ownership is 49.46%. The most recent insider transaction that took place on Mar 04 ’25, was worth 127,000. Before that another transaction happened on Mar 04 ’25, when Company’s Director sold 25,000 for $5.10, making the entire transaction worth $127,535. This insider now owns 166,879 shares in total.
Organogenesis Holdings Inc (ORGO) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 626.00% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Take a look at Organogenesis Holdings Inc’s (ORGO) current performance indicators. Last quarter, stock had a quick ratio of 3.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.12. Likewise, its price to free cash flow for the trailing twelve months is 129.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.01, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach 0.19 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Organogenesis Holdings Inc (NASDAQ: ORGO) saw its 5-day average volume 1.66 million, a negative change from its year-to-date volume of 1.78 million. As of the previous 9 days, the stock’s Stochastic %D was 50.86%. Additionally, its Average True Range was 0.43.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 36.11%, which indicates a significant increase from 36.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 98.31% in the past 14 days, which was lower than the 135.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.30, while its 200-day Moving Average is $3.40. Nevertheless, the first resistance level for the watch stands at $4.50 in the near term. At $4.75, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.21. If the price goes on to break the first support level at $3.79, it is likely to go to the next support level at $3.33. The third support level lies at $3.08 if the price breaches the second support level.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
The company with the Market Capitalisation of 540.30 million has total of 126,828K Shares Outstanding. Its annual sales at the moment are 482,040 K in contrast with the sum of 860 K annual income. Company’s last quarter sales were recorded 126,660 K and last quarter income was 7,670 K.
